Current frontline endocrine treatment options for women with hormone receptorpositive, Human Epidermal Growth Factor Receptor 2 (HER2)-negative advanced-stage breast cancer
Despite the recent advances in breast cancer early detection and awareness, a significant portion of patients present with an advanced-stage disease and more patients will progress to stage IV despite adequate treatment of their initial early-stage disease. Hormone receptor (HR)-positive, Human Epid...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Col·lecció: | Hematology/Oncology and Stem Cell Therapy |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.1016/j.hemonc.2018.04.002 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|